Status:
COMPLETED
Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Moi University
Conditions:
Fever
Malaria
Eligibility:
All Genders
1+ years
Phase:
NA
Brief Summary
There are compelling medical and public health reasons to reduce unnecessary consumption of antimalarials and strong evidence to support the use of RDTs in malaria case management. The primary study h...
Eligibility Criteria
Inclusion
- Client is older than 1 year
- Client has fever or history of fever or feeling unwell with a malaria-like illness within the last 24 hours
- Client or their parent/legal guardian consents to participate
Exclusion
- Client has signs of severe disease or other problem requiring immediate referral to a community health worker (CHW) / health facility
- Client has already sought treatment, purchased medicine or taken medicine for the current illness.
- Note:
- If more than one febrile person who meet the inclusion criteria are found in a single household, all of the individuals will be enrolled in the same group, but only one individual (the first enrolled) will be used for the purposes of the analysis.
Key Trial Info
Start Date :
June 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
444 Patients enrolled
Trial Details
Trial ID
NCT02199977
Start Date
June 1 2014
End Date
July 1 2015
Last Update
December 15 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Moi University
Eldoret, Kenya